Applying a Pareto-Based Efficiency Frontier to Inform Value-Based Pricing for Gaucher Disease Therapies in Brazil.
Journal: Pharmacoepidemiology and drug safety
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Borin MC, Gargano LP, Acurcio FA, et al. (2026). "Applying a Pareto-Based Efficiency Frontier to Inform Value-Based Pricing for Gaucher Disease Therapies in Brazil.". Pharmacoepidemiology and drug safety. https://doi.org/10.1002/pds.70497